AMR Bio is a startup based in the United Kingdom. Brouky records 1 investor associated with the company.
AMR Bio is a clinical‑stage biotechnology company developing novel anti‑infective therapeutics. The company is focused on advancing clinical candidates for treating infectious diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.